or Try an Advanced Search...

    Technical Analysis for PSTX - Poseida Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 2.72 -1.81% -0.05
    PSTX closed down 1.81 percent on Wednesday, November 20, 2024, on 81 percent of normal volume. It ran into resistance at its 50 day moving average.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical PSTX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    Calm After Storm Range Contraction 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish -1.81%
    50 DMA Resistance Bearish -1.81%
    MACD Bearish Signal Line Cross Bearish -1.81%
    Calm After Storm Range Contraction -1.81%
    NR7 Range Contraction -1.81%
    Older End-of-Day Signals for PSTX ...

       Recent Intraday Alerts

    Alert Time
    Outside Day about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    Possible NR7 about 18 hours ago
    Down 3% about 19 hours ago
    60 Minute Opening Range Breakdown about 19 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    PSTX Chart by TradingView
    Basic chart:

    Profile

    Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis

    Is PSTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline
    Nov 12 Poseida Therapeutics, Inc. (PSTX) Is Up 24.70% in One Week: What You Should Know
    Nov 11 Poseida Therapeutics to Present at Two Upcoming Investor Conferences
    Nov 9 Poseida Therapeutics Third Quarter 2024 Earnings: Beats Expectations
    Nov 8 Poseida Therapeutics GAAP EPS of $0.21, revenue of $71.7M
    Nov 7 Poseida Therapeutics, Inc. (PSTX) Q3 Earnings and Revenues Beat Estimates
    Nov 7 Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024
    Nov 5 Poseida Therapeutics to Present Clinical and Preclinical Data on Investigational Allogeneic CAR-T Cell Therapies at SITC 2024 and ASH 2024
    Nov 5 Organogenesis Holdings And 2 Other US Penny Stocks To Watch
    Oct 24 Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema
    See more PSTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.27
    52 Week Low 1.87
    Average Volume 543,928
    200-Day Moving Average 2.96
    50-Day Moving Average 2.80
    20-Day Moving Average 2.79
    10-Day Moving Average 3.08
    Average True Range 0.26
    RSI (14) 47.09
    ADX 25.34
    +DI 22.51
    -DI 21.52
    Chandelier Exit (Long, 3 ATRs) 3.05
    Chandelier Exit (Short, 3 ATRs) 3.11
    Upper Bollinger Bands 3.59
    Lower Bollinger Band 1.99
    Percent B (%b) 0.46
    BandWidth 57.57
    MACD Line 0.07
    MACD Signal Line 0.09
    MACD Histogram -0.0228
    Fundamentals Value
    Market Cap 260.1 Million
    Num Shares 95.6 Million
    EPS -1.54
    Price-to-Earnings (P/E) Ratio -1.77
    Price-to-Sales 6.92
    Price-to-Book 2.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.01
    Resistance 3 (R3) 3.01 2.91 2.96
    Resistance 2 (R2) 2.91 2.84 2.91 2.94
    Resistance 1 (R1) 2.82 2.80 2.77 2.82 2.93
    Pivot Point 2.72 2.72 2.70 2.72 2.72
    Support 1 (S1) 2.63 2.65 2.58 2.63 2.51
    Support 2 (S2) 2.53 2.61 2.53 2.50
    Support 3 (S3) 2.44 2.53 2.48
    Support 4 (S4) 2.44